KIT and myocardial ischemia: Here, we show that knocking down miR-192-5p and miR-432-5p in cardiac c-kit+ cell (CPC)–derived sEVs enhances the therapeutic capabilities of sEVs in vitro and in a rat in vivo model of cardiac ischemia reperfusion.